SUPN Supernus Pharmaceuticals
- 36.700
- -0.610-1.63%
Supernus Pharmaceuticals所有资讯
Supernus Pharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-Armistice Capital, LLC(9.25%),Steven Boyd(9.25%)
Supernus Pharmaceuticals | 4：持股变动声明-董事 NEWHALL CHARLES W III
Supernus Pharmaceuticals | 4：持股变动声明-董事 Hudson Frederick M.
Supernus Pharmaceuticals | 4：持股变动声明-董事 GEMAYEL GEORGES
Supernus Pharmaceuticals | 4：持股变动声明-高管 Khattar Jack A.
Supernus Pharmaceuticals | 144：拟议出售证券
Supernus Pharmaceuticals | 144：拟议出售证券
Supernus Pharmaceuticals | 144：拟议出售证券
Supernus Pharmaceuticals | 144：拟议出售证券
Supernus Pharmaceuticals | 4：持股变动声明-高管 Mottola Frank
Supernus Pharmaceuticals | 4：持股变动声明-高管 Khattar Jack A.
Supernus Pharmaceuticals | 4：持股变动声明-董事 GEMAYEL GEORGES
Supernus Pharmaceuticals | 144：拟议出售证券
Supernus Pharmaceuticals | 144：拟议出售证券
Supernus Pharmaceuticals | 144：拟议出售证券
Supernus Pharmaceuticals | 10-Q：2024财年三季报
Supernus Pharmaceuticals | 8-K：Supernus 公布2024年第三季度财务业绩
Supernus Pharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-Macquarie Group Limited(4.78%),Macquarie Management Holdings Inc(4.78%)等
Supernus Pharmaceuticals | SC 13G：超过5%持股股东披露文件-Dimensional Fund Advisors LP(5.2%)
Supernus Pharmaceuticals | 8-K：重大事件
暂无数据